经济观察网雅创电子（301099）发布公告，为公司子公司上海旭择电子零件有限公司新增提供1,100万 元连带责任保证担保，有效期三年。截至公告日，公司累计担保余额为86,264.47万元，占最近一期经审 计母公司净资产比例的69.49%。 近7个交易日内，雅创电子股价呈现震荡走势。截至2026年2月11日收盘，股价报46.00元，单日下跌 0.28%，近5日累计跌幅为2.11%。期间最高价为2月9日的47.08元，最低价为2月6日的44.10元，振幅达 6.34%。资金流向方面，2月11日主力资金净流出536.94万元，散户资金净流入536.94万元，显示短期资 金分歧。技术面上，股价当前处于布林带下轨附近，20日均线形成压力，短期表现弱于电子板块平均水 平。 以上内容基于公开资料整理，不构成投资建议。 股票近期走势 ...

证券日报网讯2月9日，雅创电子（301099）发布公告称，截至本公告披露日，公司及控股子公司预计 2025年度为控股子公司提供34亿元人民币担保额度(其中为控股子公司开展采购业务预计提供9亿元人民 币)，在银行授信业务项下，提供担保总余额人民币86264.47万元(含本次)，占公司最近一期经审计归母 净资产69.49%；上市公司及其控股子公司对合并报表外单位提供的担保总余额0万元，占上市公司最近 一期经审计净资产0.00%。除上述担保事项外，公司及子公司无其他在银行授信业务项下对外担保情 况，也不存在逾期担保或涉及诉讼的担保、因担保被判决败诉而应承担损失的情形，亦无为股东、实际 控制人及其关联方提供担保的情况。 ...

（来源：淘金ETF） 1. 创新医疗（002173） 深耕医疗服务赛道多年，旗下博灵医疗是国内脑机接口临床转化的核心力量，依托神经康复领域的长期 积累，在脑机设备研发与临床应用上具备先发优势。以医疗服务为核心，覆盖神经康复、心血管诊疗等 板块，同时推进脑机接口技术研发与临床转化，聚焦重度神经损伤患者的功能重建。旗下博灵BCI-4000 脑机产品已进入Ⅲ期临床，通过侵入式电极采集脑电信号，实现意念操控设备，助力高位截瘫患者康 复，是国内少数进入临床后期的脑机企业。随着脑机接口医保收费政策落地，临床转化进程将加速，产 品获批后有望成为国内首批商用侵入式脑机设备，神经康复业务有望迎来量价齐升。 2. 汤姆猫（300459） 依托"会说话的汤姆猫"等知名IP，在数字娱乐领域积累了深厚的用户基础，近年积极布局AI与脑机接口 融合赛道，探索沉浸式交互新场景。核心业务为IP运营、移动应用开发与数字内容创作，聚焦休闲娱乐 与儿童教育领域，同时推进脑机接口+AI交互技术研发。探索脑控游戏、沉浸式娱乐等应用，通过非侵 入式脑机设备采集用户意念，实现游戏操控与内容交互，打造"脑控娱乐"新体验。随着脑机接口在消费 级场景的渗透，有望 ...

证券代码：301099 证券简称：雅创电子 公告编号：2026-008 上海雅创电子集团股份有限公司 关于为子公司提供担保的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 特别风险提示： 上海雅创电子集团股份有限公司（以下简称"公司"）2025 年度预计提供担保 总额度已超过公司最近一期经审计净资产 100%，对资产负债率超过 70%的单位 担保总额度已超过公司最近一期经审计净资产 50%。截至公告之日，上市公司及 其控股子公司不存在对合并报表外单位提供的担保，敬请投资者注意相关风险。 一、担保情况概述 公司于 2025 年 4 月 19 日召开了第二届董事会第三十一次会议和第二届监事 会第二十七次会议，于 2025 年 6 月 27 日召开了 2024 年度股东会，审议通过了 《关于公司及控股子公司为控股子公司提供担保额度预计的议案》。为满足子公 司日常经营需要，保证子公司向业务相关方（包括但不限于银行、金融机构等， 以下简称"业务相关方"）申请综合授信（包括但不限于办理人民币或外币流动资 金贷款、并购贷款、项目贷款、贸易融资、银行承兑汇票、信用证 ...

证券代码：301099 证券简称：雅创电子 公告编号：2026-007 上海雅创电子集团股份有限公司 关于收到深圳证券交易所《关于上海雅创电子集团股份有限 公司发行股份及支付现金购买资产并募集配套资金 申请向特定对象发行股票的审核问询函》的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 上海雅创电子集团股份有限公司（以下简称"公司"）于 2026 年 2 月 5 日收 到深圳证券交易所（以下简称"深交所"）出具的《关于上海雅创电子集团股份有 限公司发行股份及支付现金购买资产并募集配套资金申请的审核问询函》（审核 函〔2026〕030005 号）（以下简称"《审核问询函》"），根据《上市公司重大资 产重组管理办法》《深圳证券交易所上市公司重大资产重组审核规则》等有关规 定，深交所重组审核机构对公司发行股份及支付现金购买资产并募集配套资金申 请文件进行了审核，并形成了审核问询问题。 公司将根据《审核问询函》的要求，会同相关中介机构逐项落实并及时提交 对《审核问询函》的回复，回复内容将通过临时公告方式及时披露，同时在披露 后通过深交所并购重组审核业务系统报送相 ...

证券日报网讯1月29日，雅创电子（301099）在互动平台回答投资者提问时表示，参股公司类比半导体 的脑电客户主要以国内客户为主。 ...

证券日报网讯1月29日，雅创电子（301099）在互动平台回答投资者提问时表示，截至2026年1月20日， 公司股东户数超过2.1万户。 ...

格隆汇1月29日丨雅创电子(301099.SZ)在投资者互动平台表示，关于公司代理存储芯片的品牌包括南 亚、铠侠及国内品牌等。 ...

Market Performance - The other electronic sector increased by 0.01% on January 28, with Keleke leading the gains [1] - The Shanghai Composite Index closed at 4151.24, up by 0.27%, while the Shenzhen Component Index closed at 14342.9, up by 0.09% [1] Top Gainers - Keleke (002782) closed at 23.33, up by 6.43% with a trading volume of 316,500 shares and a transaction value of 726 million [1] - Mindray Electronics (300656) closed at 27.64, up by 6.14% with a trading volume of 216,200 shares and a transaction value of 605 million [1] - Shannon Chip Creation (300475) closed at 175.00, up by 5.00% with a trading volume of 454,600 shares and a transaction value of 778 million [1] Top Losers - Walden Nuclear Materials (002130) closed at 29.32, down by 10.01% with a trading volume of 1,972,400 shares and a transaction value of 6.072 billion [2] - Jingquan Technology (002885) closed at 27.40, down by 3.15% with a trading volume of 151,500 shares and a transaction value of 419 million [2] - Hanzhuo Technology (301275) closed at 60.40, down by 2.89% with a trading volume of 33,600 shares and a transaction value of 206 million [2] Capital Flow - The other electronic sector experienced a net outflow of 320 million from institutional investors, while retail investors saw a net inflow of 444 million [2] - The capital flow data indicates that institutional investors withdrew funds, while retail investors increased their investments in the sector [2] Individual Stock Capital Flow - Shannon Chip Creation (300475) had a net inflow of 96.5 million from institutional investors, but a net outflow of 47.3 million from speculative funds [3] - Keleke (002782) saw a net inflow of 29.9 million from institutional investors, with a significant outflow from retail investors [3] - Mindray Electronics (300656) had a net inflow of 10.6 million from institutional investors, while retail investors withdrew funds [3]

Group 1 - Tianqi Co., Ltd. has entered the brain-computer interface (BCI) sector by investing in Suzhou Huahui Chip, focusing on high-density flexible neural electrode technology, achieving animal testing stages, and becoming a key player in domestic BCI hardware localization. The developed flexible neural electrode has 1024 channels, with signal acquisition precision and anti-interference capabilities at an internationally advanced level. The company has also completed biocompatibility surface modification technology to reduce inflammation after electrode implantation, with core patents authorized by the National Intellectual Property Administration [1][2][3] - Innovation Medical, through its subsidiary Boling Brain Machine, is one of the first companies in China to commercialize BCI rehabilitation products. The core product, Cyberlink AC5, was officially launched in October 2025, generating sales revenue of 114,000 yuan in 2025. Another product, Cyberlink AM5, has completed multi-center clinical trials and is progressing through the approval process. The company plans to establish five additional clinical cooperation centers to accelerate the application of BCI technology in treating neurological diseases [4][5][6] - iFlytek is a leading company in the non-invasive BCI field, leveraging its artificial intelligence technology to develop BCI collaborative technology. The company has established long-term partnerships with universities for research and development. Its non-invasive BCI system has been piloted in 120 schools nationwide, improving student attention by 30%. In the medical field, a collaboration with Beijing Tiantan Hospital has achieved a 92% accuracy rate in identifying abnormal brain signals for epilepsy [7][8][9] Group 2 - Jiahe Intelligent focuses on the research and mass production of BCI hardware, particularly EEG acquisition devices and core components, serving both consumer and medical-grade markets. The company has achieved large-scale production of EEG acquisition headphones with a signal recognition accuracy of 92%, primarily used in sleep monitoring and attention training. It plans to expand into overseas BCI hardware markets by 2026 [10][11][12] - Tom Cat is the first company in China to apply BCI technology in consumer scenarios, focusing on interactive games and rehabilitation training products. The company launched a mind-controlled game product in 2025, which quickly gained over 500,000 users. It also collaborates with rehabilitation institutions to develop BCI rehabilitation training systems, showing a 35% average improvement in patient motor function scores [13][14][15] - Hanwei Technology, through its subsidiary Weisheng Technology, is a leading company in the EEG sensor field, with an annual shipment of over 2 million units. The company has developed an epilepsy early warning system with an 88% accuracy rate in clinical tests. It also focuses on flexible pressure sensors for invasive BCI electrodes, addressing industry pain points [16][17][18] Group 3 - StarNet Ruijie leverages its network communication technology to develop low-power, high-stability EEG signal transmission systems and data encryption modules, becoming a core supplier for BCI data links. The developed transmission system supports real-time transmission of 1024-channel EEG signals with a latency of less than 10ms and a stability of 99.9% [19][20][21] - Yijiahe focuses on the integration of BCI and embodied intelligent robots, exploring applications in smart healthcare. The company has signed a strategic cooperation agreement to develop real-time emotional companionship and brain-controlled robots, enhancing the emotional care capabilities of robots [22][23][24] - Lihua Technology is focused on incubating and investing in the BCI sector, successfully incubating three high-tech companies in the field. The company collaborates with the Shenzhen Institute of Advanced Technology to provide comprehensive services for incubated companies, addressing development pain points [25][26][27] Group 4 - Sanbo Neurosurgery is a leading private hospital in the neurosurgery field, focusing on the clinical application and research of BCI. The company has successfully conducted an interventional BCI surgery, accumulating valuable experience for clinical applications. It is also recruiting participants for ongoing clinical trials [28][29][30] - Shiyun Circuit is a core enterprise in the PCB field, providing customized PCB products for BCI devices. The company focuses on high-density, flexible PCB designs, achieving low signal loss rates below 2% [31][32][33] - Meihua Medical is a leading supplier of core components for BCI, having entered the core supply chain for invasive BCI products. The company has developed components that have passed biocompatibility tests, ensuring long-term stability and safety for implanted devices [34][35][36]